Company / R&D Expense
Agilent Technologies R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$455.0M
FY2025
5-year range
$404.0M / $495.0M
FY2021-FY2025
Trend
-5.0%
vs FY2024
Sector context
#18 of 110
Health Care
What the data says
Agilent Technologies's r&d expense of $455M is higher than 84% of companies in the Health Care sector (FY2025). R&D Expense has fluctuated over the past 10 years, ranging from $329M in FY2018 to $495M in FY2022.
Based on SEC 10-K filings.
$455M in FY2025 with a 5-year CAGR of +3.3%. Top quartile in the Health Care sector.
Improved from $441M to $455M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -2.8%
- 5-Year CAGR
- +3.3%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 110This company $455.0M Sector average $298.2M
▼
+52.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.3%, indicating consistent growth.
- In FY2025, r&d expense decreased 5.0% year-over-year.
- Ranks #18 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2022.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $455.0M | -5.0% |
| FY2024 | $479.0M | +8.6% |
| FY2023 | $441.0M | -10.9% |
| FY2022 | $495.0M | +22.5% |
| FY2021 | $404.0M | +4.4% |
| FY2020 | $387.0M | -4.2% |
| FY2019 | $404.0M | +22.8% |
| FY2018 | $329.0M | -0.3% |
| FY2017 | $330.0M | +0.3% |
| FY2016 | $329.0M | -2.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026